Literature DB >> 31733788

Cognition and Reward Circuits in Schizophrenia: Synergistic, Not Separate.

A J Robison1, Katharine N Thakkar2, Vaibhav A Diwadkar3.   

Abstract

Schizophrenia has been studied from the perspective of cognitive or reward-related impairments, yet it cannot be wholly related to one or the other process and their corresponding neural circuits. We posit a comprehensive circuit-based model proposing that dysfunctional interactions between the brain's cognitive and reward circuits underlie schizophrenia. The model is underpinned by how the relationship between glutamatergic and dopaminergic dysfunction in schizophrenia drives interactions between cognition and reward circuits. We argue that this interaction is synergistic: that is, deficits of cognition and reward processing interact, and this interaction is a core feature of schizophrenia. In adopting this position, we undertake a focused review of animal physiology and human clinical data, and in proposing this synergistic model, we highlight dopaminergic afferents from the ventral tegmental area to nucleus accumbens (mesolimbic circuit) and frontal cortex (mesocortical circuit). We then expand on the role of glutamatergic inputs to these dopamine circuits and dopaminergic modulation of critical excitatory pathways with attention given to the role of glutamatergic hippocampal outputs onto nucleus accumbens. Finally, we present evidence for how in schizophrenia, dysfunction in the mesolimbic and mesocortical circuits and their corresponding glutamatergic inputs gives rise to clinical and cognitive phenotypes and is associated with positive and negative symptom dimensions. The synthesis attempted here provides an impetus for a conceptual shift that links cognitive and motivational aspects of schizophrenia and that can lead to treatment approaches that seek to harmonize network interactions between the brain's cognition and reward circuits with ameliorative effects in each behavioral domain.
Copyright © 2019 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Circuits; Cognition; Genetics; Reward; Schizophrenia; Translation

Mesh:

Year:  2019        PMID: 31733788      PMCID: PMC6946864          DOI: 10.1016/j.biopsych.2019.09.021

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  188 in total

Review 1.  Contextual fear, gestalt memories, and the hippocampus.

Authors:  M S Fanselow
Journal:  Behav Brain Res       Date:  2000-06-01       Impact factor: 3.332

2.  Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia.

Authors:  Tsuyoshi Miyakawa; Lorene M Leiter; David J Gerber; Raul R Gainetdinov; Tatyana D Sotnikova; Hongkui Zeng; Marc G Caron; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-08       Impact factor: 11.205

Review 3.  The hippocampal-VTA loop: controlling the entry of information into long-term memory.

Authors:  John E Lisman; Anthony A Grace
Journal:  Neuron       Date:  2005-06-02       Impact factor: 17.173

4.  Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia.

Authors:  Gregory P Strauss; Michael J Frank; James A Waltz; Zuzana Kasanova; Ellen S Herbener; James M Gold
Journal:  Biol Psychiatry       Date:  2010-12-17       Impact factor: 13.382

Review 5.  GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.

Authors:  Stephan Heckers; Christine Konradi
Journal:  Schizophr Res       Date:  2014-10-18       Impact factor: 4.939

6.  Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons.

Authors:  S B Floresco; C L Todd; A A Grace
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

Review 7.  Emerging role of CaMKII in neuropsychiatric disease.

Authors:  A J Robison
Journal:  Trends Neurosci       Date:  2014-07-30       Impact factor: 13.837

8.  The cognitive neuroscience of memory function and dysfunction in schizophrenia.

Authors:  Charan Ranganath; Michael J Minzenberg; J Daniel Ragland
Journal:  Biol Psychiatry       Date:  2008-05-21       Impact factor: 13.382

9.  Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome.

Authors:  Eric Granholm; Jason Holden; Peter C Link; John R McQuaid; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-10       Impact factor: 4.105

10.  Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking.

Authors:  Garret D Stuber; Dennis R Sparta; Alice M Stamatakis; Wieke A van Leeuwen; Juanita E Hardjoprajitno; Saemi Cho; Kay M Tye; Kimberly A Kempadoo; Feng Zhang; Karl Deisseroth; Antonello Bonci
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

View more
  17 in total

1.  Motor abnormalities, depression risk, and clinical course in adolescence.

Authors:  Katherine S F Damme; Jadyn S Park; Teresa Vargas; Sebastian Walther; Stewart A Shankman; Vijay A Mittal
Journal:  Biol Psychiatry Glob Open Sci       Date:  2021-07-03

2.  Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study.

Authors:  Johanna Seitz-Holland; Joanne D Wojcik; Suheyla Cetin-Karayumak; Amanda E Lyall; Ofer Pasternak; Yogesh Rathi; Mark Vangel; Godfrey Pearlson; Carol Tamminga; John A Sweeney; Brett A Clementz; David A Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Sinead Kelly; Martha E Shenton; Matcheri S Keshavan; Raquelle I Mesholam-Gately; Marek Kubicki
Journal:  Mol Psychiatry       Date:  2022-08-18       Impact factor: 13.437

3.  Importin α3 (KPNA3) Deficiency Augments Effortful Reward-Seeking Behavior in Mice.

Authors:  Yoshiatsu Aomine; Koki Sakurai; Tom Macpherson; Takaaki Ozawa; Yoichi Miyamoto; Yoshihiro Yoneda; Masahiro Oka; Takatoshi Hikida
Journal:  Front Neurosci       Date:  2022-06-30       Impact factor: 5.152

Review 4.  Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits.

Authors:  Sugai Liang; Yue Wu; Li Hanxiaoran; Andrew J Greenshaw; Tao Li
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-07       Impact factor: 2.989

5.  Depression and Psychosis Risk Shared Vulnerability for Motor Signs Across Development, Symptom Dimensions, and Familial Risk.

Authors:  Katherine S F Damme; Jadyn S Park; Sebastian Walther; Teresa Vargas; Stewart A Shankman; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

6.  Schizophrenia and bipolar disorder are associated with opposite brain reward anticipation-associated response.

Authors:  Jason Smucny; Laura M Tully; Amber M Howell; Tyler A Lesh; Sheri L Johnson; Randall C OʼReilly; Michael J Minzenberg; Stefan Ursu; Jong H Yoon; Tara A Niendam; J Daniel Ragland; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2021-01-15       Impact factor: 7.853

Review 7.  Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease.

Authors:  Emily E Oliver; Erin K Hughes; Meaghan K Puckett; Rong Chen; W Todd Lowther; Allyn C Howlett
Journal:  Biomolecules       Date:  2020-11-27

Review 8.  Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia.

Authors:  Qiongqiong Wu; Jing Huang; Renrong Wu
Journal:  Front Neurosci       Date:  2021-04-12       Impact factor: 4.677

9.  Disordered directional brain network interactions during learning dynamics in schizophrenia revealed by multivariate autoregressive models.

Authors:  Shahira J Baajour; Asadur Chowdury; Patricia Thomas; Usha Rajan; Dalal Khatib; Caroline Zajac-Benitez; Dimitri Falco; Luay Haddad; Alireza Amirsadri; Steven Bressler; Jeffery A Stanley; Vaibhav A Diwadkar
Journal:  Hum Brain Mapp       Date:  2020-05-21       Impact factor: 5.038

Review 10.  Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.

Authors:  Santiago J Ballaz; Michel Bourin
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.